Minimal Residual Disease (MRD) Testing News and reporting on minimal residual disease testing. C2i Genomics, NovogeneAIT Genomics Partner to Launch Cancer Detection Platform in Southeast Asia C2i's platform uses artificial intelligence pattern recognition and whole-genome analysis to detect minimal residual disease in blood samples from cancer patients. Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications Research presented at the ASCO meeting described efforts to expand the use of existing technologies into new directions. Foresight Diagnostics Raises $12.5M in Series A to Commercialize MRD Detection Tech The company, founded by Stanford University scientists, is advancing a technology called PhasED-Seq for cancer minimal residual disease detection. Guardant Health Sues Natera for False Advertising, 'Misleading' Oncologists About MRD Tests Guardant has asked the court to recover damages and to prevent Natera from further disseminating "deceptive" advertising regarding their competing assays. F-Star Therapeutics to Use Inivata's RaDaR Assay in Clinical Studies F-star will use the ctDNA assay to identify potential early biomarkers of clinical efficacy and evaluate treatment response for late-stage solid tumors. May 19, 2021 Colorectal Cancer Relapse Can Be Predicted by ctDNA Clearance, Study Shows May 11, 2021 Biocartis Receives €1.4M Grant to Develop New Technology for Molecular Surveillance May 7, 2021 Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape Premium May 6, 2021 Guardant Health Q1 Revenues up 17 Percent Apr 28, 2021 NuProbe, AcornMed to Develop Cancer Minimal Residual Disease Detection Products Apr 1, 2021 Guardant Health Receives New York State Approval for Guardant Reveal MRD Test Mar 27, 2021 Liquid Biopsy MRD Detection Eyed as Decision Tool for Oligometastatic Colorectal Cancer Patients Premium Mar 15, 2021 Dana Farber Team Applies PCR Method to ID Microsatellite Instability in Tumor-Derived Samples Premium Mar 11, 2021 Broad Team to Improve Minimal Residual Disease Detection With Mutation Enrichment Sequencing Method Premium Mar 4, 2021 C2i Genomics Acquires Sequencing Lab QNA Dx Mar 2, 2021 Twist Bioscience, Watchmaker Genomics Partner on High-Throughput NGS Applications Feb 26, 2021 Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium Feb 26, 2021 Personalis to Broaden Liquid Biopsy Footprint With Minimal Residual Disease Testing Premium Feb 26, 2021 Guardant Health Begins First Foray Into Early-Stage Cancer With Commercial MRD Test Launch Premium Feb 23, 2021 Adaptive Biotechnologies, LabCorp Expand Collaboration Feb 17, 2021 Natera, Personalis Team up for Cancer Treatment Monitoring, MRD Testing Feb 16, 2021 Exact Sciences Q4 Revenues up 58 Percent; Company to Acquire Ashion Analytics From TGen Feb 4, 2021 Inivata Raises $35M in Second Close of Series C Financing Round Jan 20, 2021 Natera Sues Inivata, Alleging Infringement of Cancer Testing Patents Jan 14, 2021 Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.